Domzalski David

CEO at Foamix Pharmaceuticals Ltd.

Sold, on record
$114k
Dollars the filings state
Form 4 sales
12
Latest Jul 1, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Foamix Pharmaceuticals Ltd.Unusual
    Aug 8, 2018 2018

    Sold 8,238 shares at $5.68 ($47k)

    Domzalski David, CEO

    Sold 5.1% of holdings ($923k position)154,243 shares left24.6x usual sizeFiling

  2. 2 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not stated
    Sep 4, 2018 +27 days

    Sold 67 shares at $5.67 ($380)

    Domzalski David, CEO

    Sold 0% of holdings ($875k position)154,176 shares left0.1x usual sizeFiling

  3. 3 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not stated
    Oct 1, 2018 +27 days

    Sold 601 shares at $5.81 ($3k)

    Domzalski David, CEO

    Sold 0.4% of holdings ($896k position)153,575 shares left1.8x usual sizeFiling

  4. 4 Form 4 sale Foamix Pharmaceuticals Ltd.Unusual
    Nov 8, 2018 +38 days

    Sold 2,062 shares at $4.58 ($9k)

    Domzalski David, CEO

    Sold 1.3% of holdings ($703k position)151,513 shares left3.4x usual sizeFiling

  5. 5 Form 4 sale Foamix Pharmaceuticals Ltd.Unusual
    Nov 19, 2018 +11 days

    Sold 5,036 shares at $3.90 ($20k)

    Domzalski David, CEO

    Sold 3.3% of holdings ($591k position)146,477 shares left8.4x usual sizeFiling

  6. 6 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not stated
    Dec 3, 2018 +14 days

    Sold 68 shares at $4.05 ($275)

    Domzalski David, CEO

    Sold 0% of holdings ($593k position)146,409 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale Foamix Pharmaceuticals Ltd.Unusual
    Apr 1, 2019 +119 days

    Sold 5,096 shares at $3.75 ($19k)

    Domzalski David, CEO

    Sold 2.3% of holdings ($824k position)214,595 shares left8.5x usual sizeFiling

  8. 8 Form 4 sale Foamix Pharmaceuticals Ltd.Unusual
    Jul 1, 2019 +91 days

    Sold 3,355 shares at $2.35 ($8k)

    Domzalski David, CEO

    Sold 1.6% of holdings ($504k position)211,240 shares left5.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Domzalski David
Source
Jul 1, 2019Jul 3, 2019Foamix Pharmaceuticals Ltd.CEOForm 4 sale3,355$8k1.6%UnusualSEC
Apr 1, 2019Apr 3, 2019Foamix Pharmaceuticals Ltd.CEOForm 4 sale5,096$19k2.3%UnusualSEC
Dec 3, 2018Dec 6, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale68$2750.0%Plan not statedSEC
Nov 19, 2018Nov 20, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale5,036$20k3.3%UnusualSEC
Nov 8, 2018Nov 13, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale2,062$9k1.3%UnusualSEC
Oct 1, 2018Oct 2, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale601$3k0.4%Plan not statedSEC
Sep 4, 2018Sep 6, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale67$3800.0%Plan not statedSEC
Aug 8, 2018Aug 9, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale8,238$47k5.1%UnusualSEC
Jul 2, 2018Jul 3, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale602$3k0.4%UnusualSEC
Jun 1, 2018Jun 4, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale67$3520.0%Plan not statedSEC
Apr 2, 2018Apr 4, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale602$3k0.4%Plan not statedSEC
Mar 1, 2018Mar 5, 2018Foamix Pharmaceuticals Ltd.CEOForm 4 sale66$3930.0%Plan not statedSEC